CVS | Cvs health corp - Stock Value & PE Ratio Analysis

3

24

15

Average Growth

AI analysis rates CVS with a medium value score of 3.
It is mainly due to adequate operating cash flow, but with concerns regarding potential value may be lower.
Over the past 3 months, CVS has maintained a consecutive value rating of 3.0, slightly lower than the rating of 4.0 over the past 3 years, indicating decreasing growth opportunities for enterprise value.
Compared to all stocks in the Health Care sector, CVS has a medium value rating.

CVS Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/05/03 (Weekly Update)

CVS Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

CVS Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	2.25	6.1%	32.4%	94.59B	1.1%	1%	1.7%
2024Q2	1.09	-50.7%	-24.3%	95.43B	6.6%	2.9%	1.9%
2024Q1	1.83	-17.2%	5.8%	91.23B	2.9%	-0.2%	1.3%
2023Q4	1.31	-40.5%	-22.9%	87.98B	3.6%	-1.5%	2.2%
2023Q3	2.12	6.5%	5.5%	93.55B	12%	3.5%	2.5%

Update to 2025/5/8 (Quarterly Update)

CVS Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

CVS Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of CVS from 2007/01 till Now

185.54%
Cumulative Return: 5.90%
Annual Return: 26.81%
Volatility: 0.22
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 2)